Comment from National Ataxia Foundation

Summary: The National Ataxia Foundation, a nonprofit patient advocacy group, supports the framework proposed by the Haystack Project in their citizen petition. They argue that the FDA should adopt more flexible trial designs, such as using natural history data as a comparator, to accelerate the development of treatments for rare and heterogeneous neurodegenerative diseases.